These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

213 related articles for article (PubMed ID: 22089727)

  • 1. Cardiology in 2011--amazing opportunities, huge challenges.
    Peterson ED; Gaziano JM
    JAMA; 2011 Nov; 306(19):2158-9. PubMed ID: 22089727
    [No Abstract]   [Full Text] [Related]  

  • 2. Definition of new targets in cardiovascular prevention from young into old age.
    Staessen JA
    Eur Heart J; 2002 Apr; 23(7):507-9. PubMed ID: 11922635
    [No Abstract]   [Full Text] [Related]  

  • 3. Hypertension and cholesterol.
    Zeron RMC; Albuquerque VC
    Rev Assoc Med Bras (1992); 2019 Dec; 65(12):1421-1422. PubMed ID: 31994618
    [No Abstract]   [Full Text] [Related]  

  • 4. Vascular disease, hypertension, and prevention: "from endothelium to clinical events".
    Hirsch AT
    J Am Coll Cardiol; 2003 Jul; 42(2):377-9. PubMed ID: 12875780
    [No Abstract]   [Full Text] [Related]  

  • 5. Controversies in cardiovascular medicine revisited.
    Estes NA
    Circulation; 2014 Oct; 130(18):1561. PubMed ID: 25462820
    [No Abstract]   [Full Text] [Related]  

  • 6. Reprint of: Cardiovascular Health Promotion: An Issue That Can No Longer Wait.
    Turco JV; Inal-Veith A; Fuster V
    J Am Coll Cardiol; 2018 Dec; 72(23 Pt B):2945-2950. PubMed ID: 30522629
    [No Abstract]   [Full Text] [Related]  

  • 7. Cholesterol, cholesterol lowering agents/statins, and urologic disease: part II--do you know your Framingham Risk Score?
    Moyad MA; Merrick GS
    Urol Nurs; 2006 Jun; 26(3):227-9, 203. PubMed ID: 16800331
    [No Abstract]   [Full Text] [Related]  

  • 8. [Cardiovascular prevention: not necessary under the age of 40].
    Walma EP
    Ned Tijdschr Geneeskd; 2009; 153():B351. PubMed ID: 19785804
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Known cardiovascular risk factors (hypertension, diabetes, hypercholesteremia): secondary and tertiary prevention in pediatric patients].
    Bonnet D; Aggoun Y
    Arch Pediatr; 2002 May; 9 Suppl 2():131s-133s. PubMed ID: 12108244
    [No Abstract]   [Full Text] [Related]  

  • 10. The Fluctuating Journal Statistics.
    Lavie CJ
    Prog Cardiovasc Dis; 2018; 61(2):270-271. PubMed ID: 29981353
    [No Abstract]   [Full Text] [Related]  

  • 11. JACC Serving the Global Cardiovascular Community.
    Fuster V; Oetgen WJ
    J Am Coll Cardiol; 2018 Nov; 72(20):2531-2533. PubMed ID: 30361078
    [No Abstract]   [Full Text] [Related]  

  • 12. [A critical analysis of intervention in cardiovascular risk factors].
    Jiménez Mena C; Rodríguez Sánchez E; Martínez Ibáñez MT; Morales Jiménez P; Cervera Valverde C; Segura Hernández E
    Aten Primaria; 1991 Sep; 8(8):636-8, 640-2, 644-8. PubMed ID: 16986249
    [No Abstract]   [Full Text] [Related]  

  • 13. [Control and prevention of cardiovascular diseases].
    Wu ZL
    Zhonghua Yu Fang Yi Xue Za Zhi; 2005 Jan; 39(1):5-6. PubMed ID: 15794879
    [No Abstract]   [Full Text] [Related]  

  • 14. [Consensus for the control of cholesterolemia and hypertension and the prevention of cardiovascular diseases in Spain].
    Balaguer Vintro I
    Rev Sanid Hig Publica (Madr); 1990; 64(7-8):343-6. PubMed ID: 2131616
    [No Abstract]   [Full Text] [Related]  

  • 15. A Letter to the (Founding) Editor: A King by Any Name.
    Moliterno DJ
    JACC Cardiovasc Interv; 2017 Jul; 10(13):1378-1379. PubMed ID: 28683945
    [No Abstract]   [Full Text] [Related]  

  • 16. [Detecting risk factors in cardiology].
    Manus JM
    Rev Infirm; 2000 Mar; (58):45-6. PubMed ID: 11075165
    [No Abstract]   [Full Text] [Related]  

  • 17. [Cardiology].
    Qi W; Xie Y; Lu G
    Zhonghua Yi Xue Za Zhi; 2002 Dec; 82(24):1657-9. PubMed ID: 12641912
    [No Abstract]   [Full Text] [Related]  

  • 18. Qualitative Methodology in Cardiovascular Outcomes Research: A Contemporary Look.
    McIlvennan CK; Morris MA; Guetterman TC; Matlock DD; Curry L
    Circ Cardiovasc Qual Outcomes; 2019 Sep; 12(9):e005828. PubMed ID: 31510771
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [What future for cardiovascular prevention trials?].
    Scheen AJ
    Rev Med Suisse; 2009 Aug; 5(214):1635-6. PubMed ID: 19772193
    [No Abstract]   [Full Text] [Related]  

  • 20. Cardiovascular risk factors in perspective.
    Carruthers SG
    Can Fam Physician; 1993 Feb; 39():309-14. PubMed ID: 8495121
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.